The key objective was to demonstrate the powerful applications of Intel's AI technology for their healthcare business with video content that creates an emotional connection and appeals to both B2B and B2C audiences. We aimed to show how Intel technology is improving cancer diagnosis, treatment, care and ultimately quality of life in an emotional, first person profile. Bryce's inspiring journey was a vehicle to introduce amazing medical advancements in a way that engages viewers' hearts and minds.
Freethink told the story of an Intel employee, Bryce Olson, who was diagnosed with stage 4 prostate cancer. When the standard of care didn't work, Bryce turned to genomic sequencing, which allowed his doctors to identify specific genetic drivers of his disease and specific treatments and clinical trials that were a fit for his cancer. This precision medicine approach helped send his cancer into remission for several years. Now Bryce is working with Intel partners like the Broad Institute and other leaders in the field of advanced cancer research to use artificial intelligence powered by Intel technology to discover new, innovative solutions that can help him and millions of others like him around the world.
Intel published this video through its own digital channels and Freethink created social cutdowns & ads targeting Intel's B2B and B2C audience segments. Freethink also published through its website and social channels (Facebook and YouTube) where its audience comprises 1+ million subscribers who are typically 18-44 years old and over-index as high-earning and highly-educated with a relatively even mix of male and female viewers.
Freethink delivered 3+ million views and 9+ million brand impressions. Intel's distribution included an additional 8+ million views. The video was the 5th most popular video ever on Intel's YouTube channel and the most popular over 90 seconds long. Additionally, there were 800+ comments, 4,000+ shares, and 8,000+ likes.
